Dear Members,
You are invited to join Dr. Daniel Weiner for the 17th Advanced Level Workshop
on Pharmacokinetic-Pharmacodynamic Data Analysis in Munich, Germany. Secure
your place by registering early and receive a 20% discount! (expires 18 March
2015)
Interested in a custom on-site training course? Follow the link to view the
benefits of on-site training and to request a proposal:
http://info.certara.com/contact-us-for-custom-on-site-training
17th Advanced Level Workshop on Pharmacokinetic - Pharmacodynamic Data Analysis
May 18-21, 2015
Munich, Germany
Register Here: https://www.certara.com/training/classes/73
Learn to apply advanced approaches for conducting PK/PD analysis. This course
aims to give the course participants confidence and encouragement to have a go
at PK/PD and to practice PK/PD data analysis on real life case studies from
discovery, preclinical and development. The program is comprised of lectures
and group exercises with discussion, combined with hands-on PK/PD data analysis
sessions.
Who should attend?
Scientists with at least five years of experience in PK/PD modeling. Qualified
graduate students.
Topics include:
Dose-response-time analysis, advanced principles of turnover modeling including
modeling tolerance and rebound, approaches to TMDD modeling, approaches to
optimizing sampling collection times, modeling PD effects for combination drug
treatments, pattern recognition, and translational aspects of PK/PD modeling.
Course includes:
Complimentary copy of Pharmacokinetic & Pharmacodynamic Data Analysis [with
CDROM] by Johan Gabrielsson and Dan Weiner.
Lectures, group exercises with discussion, and hands-on PK/PD data analysis
including population PK/PD modeling using Phoenix WinNonlin and NLME.
Discussions and exercises will enable participants to master state-of-the-art
approaches to real-life problems.
Daniel Weiner Ph.D.
Dr. Weiner has extensive drug development experience and has served as an
expert consultant to the U.S. Food and Drug Administration (FDA) on
pharmacokinetic modeling and bioequivalence assessment. Prior to his previous
tenure with Pharsight as a Senior Vice President, Dr. Weiner held several
management positions including Head, Biostatistics, Merrell Dow
Pharmaceuticals; Vice President, Statistical Consultants, Inc.; Vice President,
Syntex Development Research; Senior Vice President and Principal Scientist,
Quintiles, and most recently, Senior Vice President and Global Head of Clinical
Development at IVAX Research.
Kind regards,
Andre Keller
Certara(tm)
5520 Dillard Dr., Suite 260
Cary, NC 27518
Tel +1-919-852-4611
http://www.certara.com/